Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-29

Clinical Trial Update: Gluten and Amylase Trypsin Inhibitors (ATI) Free Diet [NA]

View source ↗

Summary

This completed clinical trial evaluated a gluten- and amylase-trypsin inhibitors (ATI)-free diet in people with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Type1diabetes | NA | Status: COMPLETED